CC Chemokine Receptor 2 Is Required for Macrophage Infiltration and Vascular Hypertrophy in Angiotensin II–Induced Hypertension
- 1 September 2000
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 36 (3), 360-363
- https://doi.org/10.1161/01.hyp.36.3.360
Abstract
Abstract —Recent studies have identified the presence of macrophages in the arterial wall of hypertensive animals and suggested that as is the case in atherosclerosis, macrophage products may be important mediators of the adaptive response of the arterial wall. In support of this, we have previously shown that the expression of monocyte chemoattractant protein-1 is upregulated in the arteries of hypertensive animals. We hypothesized that macrophage recruitment is a critical step in the pathogenesis of hypertension. To obtain insights into this potential mechanism, we made use of mice deficient in the CC chemokine receptor 2 (CCR2), the receptor for monocyte chemoattractant protein-1. Hypertension was induced with the subcutaneous administration of angiotensin II (0.75 mg · kg −1 · d −1 ) for 7 days. Using in situ hybridization with a probe for c- fms to identify macrophages, we found that hypertension-induced macrophage infiltration of the arterial wall was virtually eliminated in CCR2-deficient mice. In addition, vascular hypertrophy was reduced by ≈65% compared with wild-type animals. These data demonstrate that CCR2 is essential for the recruitment of macrophages into the arterial wall in the setting of hypertension. Furthermore, the decreased hypertrophic response suggests that vascular hypertrophy occurs in part as a consequence of macrophage infiltration. In angiotensin II–induced hypertension, CCR2-mediated responses are critical to the process of macrophage recruitment and vascular hypertrophy and may represent one mechanism by which at least some forms of hypertension may lead to the development of atherosclerosis.Keywords
This publication has 11 references indexed in Scilit:
- MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein BJournal of Clinical Investigation, 1999
- Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient MiceMolecular Cell, 1998
- Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.Journal of Clinical Investigation, 1996
- Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase.Journal of Clinical Investigation, 1993
- Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.Proceedings of the National Academy of Sciences, 1992
- Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition.Hypertension, 1991
- Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.Proceedings of the National Academy of Sciences, 1991
- Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit.Hypertension, 1989
- The effects of coarctation hypertension upon vascular inositol phospholipid hydrolysis in Wistar ratsJournal Of Hypertension, 1988
- Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984